Nigel Lindner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The COVID-19 pandemic has accelerated the adoption of telehealth, vaccine manufacturing, and point-of-care diagnostics, improving patient access to immediate care. In this episode, we welcome Nigel Lindner, the chief innovation officer at LumiraDx, to discuss the transformative impact of point-of-care diagnostics on our health care system. From reducing health inequalities to improving patient outcomes, Nigel explores the ways in which these technologies are revolutionizing health care delivery. He also highlights the importance of scaling up these innovations to reach vulnerable populations a...

Mumbai (Maharashtra) [India], November 24 (ANI/NewsVoir): LumiraDx Healthcare Private Limited, a next-generation point of care diagnostics testing company, announced it has launched its highly sensitive C-Reactive Protein (CRP) point of care antigen test across India.

Toronto, ON (PRWEB) July 29, 2022 -- Advancements in point-of-care (POC) testing are impacting health systems.COVID-19 exposed tremendous gaps in health

/PRNewswire/ -- LumiraDx Limited (Nasdaq: LMDX), a next-generation point of care diagnostics company, announced today that its rapid COVID-19 antigen assay,...

LONDON, Jan. 14, 2022 /PRNewswire/ -- LumiraDx , a next-generation point of care diagnostics company, today announced that results from ongoing testing and monitoring of COVID-19 variants show... | January 14, 2022